Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,235,665
+$3,763,018 QoQ
Shares Held
91,070
+857.6% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#66
of 331 holders
Holding Since
Sep 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $59,184,383 across 9 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
191,841 | $15,295,482 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,742,942 | $13,804,100 | |
| 3 | VTRS |
Viatris Inc
|
727,900 | $11,559,052 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
151,208 | $4,747,931 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
180,430 | $4,440,382 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
91,070 | $4,235,665 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
131,400 | $2,651,652 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
63,470 | $2,200,504 |
All Filings in SUPN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,235,665 | 91,070 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $472,647 | 9,510 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,353,890 | 28,330 | Shares | Sole | 2025-11-14 | |
| 2022-09-30 | $437,342 | 12,920 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $248,943 | 8,608 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $219,064 | 6,778 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $212,159 | 7,955 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||